Orders from 120 EUR Free delivery from 250 EUR Ready for pickup dead drop: collect in 5 min

Cocaine

Cocaine

First-hand direct import from Colombia. Opening the pack gives an intense smell close to horseradish.

Chemical name
Other names
CAS number
Molecular formula
Molecular weight
Chemical form
Physical appearance
Opening the pack gives an intense smell close to horseradish.
Country of origin
Condition
New

Click here to collect in 5 minutes

Courier price 80.00 EUR

Portion

80.00 EUR / 1 g 80.00 EUR

  • External lab verification (≥98%) and full CAS properties sheet on the product card.
  • Discreet unbranded parcel (locker / courier) or ready dead-drop pickup in your city.
  • No mandatory registration required (BTC / XMR) · 24/7 live chat (14:00–22:00 chemist shift).

5.0 (11)

First-hand direct import from Colombia. Opening the pack gives an intense smell close to horseradish. This is a high-purity product. It was received as 98% crack, not oil.

Cocaine belongs to the “Cocaine” category. Verified identity and physicochemical parameters are shown in the product properties table.

Verified Neurochemical & Toxicological Intelligence

Cocaine (Benzoylmethylecgonine / Cocaine HCl)

Stimulant & Local Anesthetic (Balanced SNDRI) Tropane alkaloid (erythroxylum benzoylecgonine methyl ester)
Verified PubChem & CAS Identity C17H21NO4 · CAS 50-36-2 · CID 446220
Calibrated Physical Form Pure Crystalline / Analytical Powder (≥98%)
≥98% Analytical Purity Verified 303.35 g/mol
Peer-Reviewed & Agency Citations 4 · verified sources

Receptor Telemetry & Mechanism of Action

DAT Dopamine Transporter 211 nM
NET Norepinephrine Transporter 292 nM
SERT Serotonin Transporter 313 nM

Balanced triple monoamine reuptake inhibitor (SNDRI: DAT IC50 = 211 ± 19 nM, NET IC50 = 292 ± 34 nM, SERT IC50 = 313 ± 17 nM; DAT/SERT ratio = 1.5) combined with topical local anesthetic activity and peripheral beta-adrenergic stimulation producing positive chronotropic, dromotropic, and inotropic effects on the heart. Poses unique cardiotoxic risks compared to amphetamines—linked to arrhythmias, hypertension, coronary artery disease, Takotsubo cardiomyopathy, and sudden cardiac death even with regular use.

Biotransformation & Active Metabolites

Biotransformed into inactive benzoylecgonine (primary analytical marker) and N-demethylated norcocaine; specific plasma elimination half-life figures are not detailed in the reference set, though acute mucosal psychotropic action resolves within 10–90 minutes.

Temporal Pharmacokinetics

Rapid-onset, short-acting rushing mood elevation, confident social disinhibition, ego inflation, heightened libido, and distinct local nasal/oral numbing, followed by a sharp crash.

  1. Onset 3–10 minutes mucosal (30–40 minutes oral)
  2. Peak Window 7.5–16 minutes mucosal (60–180 minutes oral)
  3. Total Window 10–90 minutes mucosal (CAHMA typical 60–90 min, core rush 10–20 min; 120–240 minutes oral)
  4. Residual / Half-Life 1–3 hours of craving, irritability, and comedown fatigue; inactive benzoylecgonine persists in urine.

mucosal peak arrives within 7.5–16 minutes and fades rapidly (primary high 10–20 minutes inside a 10–90 minute total window), fueling intense compulsive repeated exposure. PsychonautWiki notes that susceptible individuals have died from as little as 30 mg applied to mucous membranes, while chronic mucosal use causes ischemic nasal damage and septum perforation ('cocaine nose').

Quantitative Response Spectrum (Published Literature)

Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.

Threshold
5–10 mg mucosal (13 mg oral)
Cognitive & Sensory

Subtle alertness, slight mood lift, and mild reduction in fatigue.

Somatic & Autonomic

Faint nostril numbness and minor vasoconstriction in extremities.

Light
10–30 mg mucosal (13–75 mg oral)
Cognitive & Sensory

Crisp wakefulness, fluent social confidence, talkativeness, and clean mood elevation.

Somatic & Autonomic

Clear nasal/palate anesthesia, dilated pupils, mild vasoconstriction in feet/hands, and modest heart-rate increase.

Common Reference
30–60 mg mucosal (75–150 mg oral)
Cognitive & Sensory

Pronounced rushing mood elevation, ego inflation, disinhibition, heightened libido, and strong urge to redose as effects ebb.

Somatic & Autonomic

Tachycardia, elevated blood pressure, raised body temperature, appetite suppression, and local mucosal numbing.

Strong
60–90 mg mucosal (150–225 mg oral)
Cognitive & Sensory

Hyper-inflated ego, irritability, restlessness, anxiety, minor hallucinations, and harsh post-peak crash.

Somatic & Autonomic

Heavy cardiac strain, hypertension, nausea, jaw tension, and temporary erectile dysfunction.

Heavy / Toxic Zone
90+ mg mucosal (225+ mg oral; rare idiosyncratic fatalities documented from 30 mg)
Cognitive & Sensory

Acute panic, mania, paranoid psychosis, and severe agitation.

Somatic & Autonomic

Severe cardiac arrhythmias, hypertension, acute heart failure / sudden cardiac death, seizures, and brainstem respiratory-center depression at toxic levels.

Interaction Matrix & Critical Contraindications

Critical Hazard — Never Combine

Opioids, GHB/GBL, and Pregabalin

Cocaine transiently elevates respiration and masks sedation; when cocaine wears off after 15–60 minutes, unopposed opioid/GHB levels cause fatal respiratory arrest, while pregabalin + cocaine carries severe seizure, cardiac, and methemoglobinemia risks.

25x-NBOMe, 2C-T-x, MAOIs, and Tramadol

Produces severe synergistic vasoconstriction, tachycardia, malignant hypertension, seizures, and acute heart failure.

Alcohol (heavy co-consumption)

Cocaine masks subjective drunkenness while compounding cardiovascular strain and dehydration; once cocaine's brief peak drops off, unopposed alcohol depression risks blackouts and severe respiratory depression.

Elevated Hazard — Avoid

MDMA, Amphetamines, Cathinones, and Diphenhydramine

Cocaine competitively blocks some desirable effects of MDMA and dopamine releasers while sharply increasing heart-attack risk; diphenhydramine + cocaine strains the heart and risks respiratory arrest once cocaine fades.

PCP / potent Arylcyclohexylamines and DOx / 5-MeO-xxT psychedelics

Easily precipitates hypermanic states, severe body load, and anxiogenic thought loops.

Caution / Receptor Attenuation

SSRIs

May mutually reduce effectiveness at SERT while retaining cocaine's adrenergic/cardiac risks.

Cannabis and Caffeine

Caffeine increases risk of tachycardia and hypertension; cannabis heightens anxiety and thought loops.

Structural Isomer & Sibling Comparison

Unlike synthetic NDRI cathinones in our catalog (NEP, Hexen, alpha-PVP, alpha-PiHP), cocaine inhibits all three monoamine transporters almost equally (DAT/NET/SERT IC50 211–313 nM), giving it a warmer, more poised social confidence and a far shorter overall window (10–90 min mucosal vs. 6–24 h residual tails on cathinones). However, cocaine poses unique direct cardiotoxic risks of permanent heart damage and sudden cardiac death.

Physicochemical Stability & Storage

Form: White, shiny crystalline powder or flaky crystals as cocaine hydrochloride (CAS 53-21-4, C17H22ClNO4), producing topical local anesthesia on nasal and oral mucous membranes. · Cocaine hydrochloride is freely soluble in water.

Store sealed in an airtight, dry, light-resistant container at cool room temperature.

Cross-Tolerance & Dependence Profile

Rapid tolerance develops with prolonged/repeated use, with full cross-tolerance across all dopaminergic stimulants. Highly addictive with intense binge repeated exposure; chronic mucosal use causes nasal cartilage damage, septum perforation, and cocaine-induced midline destructive lesions (CIMDL).

Comprehensive Analytical & Toxicological Monograph

Cocaine hydrochloride (benzoylmethylecgonine HCl; methyl (1R,2R,3S,5S)-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate; freebase CAS 50-36-2, hydrochloride CAS 53-21-4, PubChem CID 446220) is the classical tropane alkaloid extracted from Erythroxylum coca and E. novogranatense, supplied as pure water-soluble crystalline powder or crystals (C17H21NO4, 303.35 g/mol). Pharmacologically, cocaine acts as a balanced serotonin-norepinephrine-dopamine reuptake inhibitor (DAT IC50 = 211 nM, NET IC50 = 292 nM, SERT IC50 = 313 nM; DAT/SERT ratio = 1.5) paired with topical local anesthetic activity and peripheral beta-adrenergic stimulation that exerts positive chronotropic, dromotropic, and inotropic strain on the heart. Even regular non-overdose use carries unique cardiotoxic risks compared to amphetamines, including arrhythmias, coronary disease, and sudden cardiac death. For mucosal cocaine HCl, threshold effects appear at 5–10 mg, light stimulation at 10–30 mg, common confident mood elevation at 30–60 mg, strong intensity at 60–90 mg, and heavy overdose danger above 90 mg—though fatal reactions have been documented from as little as 30 mg on mucous membranes (oral brackets span 13–75 mg light, 75–150 mg common, and 225+ mg heavy over 2–4 hours). mucosal onset takes 3–10 minutes, peaking at 7.5–16 minutes inside a 10–90 minute total window, driving frequent repeated exposure and chronic nasal septum damage. Compared to NEP and Hexen, cocaine delivers a smoother, triple-transporter social poise and resolves much faster afterward, though it is ~4.5-fold less potent at DAT than Hexen. Never mix cocaine with opioids, GHB/GBL, pregabalin, alcohol, 25x-NBOMe, 2C-T-x, MAOIs, tramadol, MDMA, or other stimulants.